0001753926-26-000845
SEC filingQ1 FY2026 delivered sharp revenue contraction and widened operating losses due to lost sales volume from a key customer and fewer units placed, despite gross margin resilience at 29%. Management's cost controls and liquidity position provide a foundation for navigating the transition.
Revenue fell 59.3% year-over-year to $3.4 million in the three months ended March 31, 2026, primarily due to lower units sold—10 versus 21 in the prior-year period. Management highlights that this reflects no units sold to a historically large customer, which had been a key demand driver but carried extended payment terms. This concentration risk materialized, underscoring vulnerability to reliance on individual clients. The shift also ties to transitional dynamics like the Fair Deal Agreement rentals, where revenue recognition spreads over time rather than at shipment, delaying top-line recognition while building long-term clinic relationships.
Gross profit contracted 77.2% to $991 thousand, but the gross margin of 29.2% demonstrated resilience relative to the steep revenue drop. Lower sales volume and customer mix changes pressured absolute dollars, yet the percentage held as management monitored inflation impacts through proactive inventory ordering to stabilize product costs. This positioning helps mitigate cost volatility during periods of reduced placements, preserving profitability framework even as scale diminished.
Operating income deteriorated 64.7% to a -$4.4 million loss from -$2.6 million, with operating margin at -128.4%. Revenue decline overwhelmed expense discipline, where decreases stemmed from lower lobbying for billing codes, reduced headcount, and scaled-back product development for next-generation systems. These actions reflect management's focus on cash preservation amid softer demand, softening the loss expansion while signaling operational adaptability.
Net income showed a modest 2.1% worsening to -$2.6 million, with diluted EPS unchanged at -$0.16. The effective tax rate rose due to projected full-year income expectations and reduced estimated tax credits proportional to pretax profit. Management monitors these alongside operating trends and business shifts for valuation allowance needs, while Tax Act provisions are expected to defer cash tax payments.